[Bartter's syndrome. Current prospects of nosographic classification and new therapeutic possibilities].
D000450:Aldosterone / Q000097:blood; D001477:Bartter Syndrome / Q000145:classification / Q000188:drug therapy; D002648:Child; D004573:Electrolytes / Q000097:blood; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000145:classification; D007213:Indomethacin / Q000627:therapeutic use*; D011188:Potassium / Q000627:therapeutic use; D011453:Prostaglandins / Q000652:urine; D012083:Renin / Q000097:blood; D012965:Sodium Chloride / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D004573:Electrolytes; D011453:Prostaglandins; D013148:Spironolactone; D012965:Sodium Chloride; D000450:Aldosterone; D012083:Renin; D011188:Potassium; D007213:Indomethacin
La sindrome di Bartter. Attuali prospettive di inquadramento nosografico e nuove possibilità terapeutiche.